ADOLOR
Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pain and pain-management products. ENTEREG (alvimopan) is the United States Food and Drug Administration (FDA) approved product. ENTEREG is indicated to accelerate upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis. The Company is conducting two Phase 2 clinical trials of ADL5945 to treat opioid... -induced constipation (OIC), a condition that often results from long-term use of opioid analgesics in the management of chronic pain conditions. In addition, it is continuing development efforts on ADL7445, a second peripherally-acting mu opioid receptor antagonist, which is considered a back-up compound in its OIC program. The Company has completed Phase 1 clinical evaluation of ADL6906 (beloxepin).
ADOLOR
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
1993-01-01
Address:
Exton, Pennsylvania, United States
Country:
United States
Website Url:
http://www.adolor.com
Total Employee:
51+
Status:
Active
Contact:
17818601407
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Atlas Therapeutics
Atlas Therapeutics focuses on the discovery, development and commercialization of muscle health and performance therapeutic products.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Insero Health
Insero Health is involved in the discovery, development and commercialization of pharmaceuticals for epilepsy and related conditions.
Kentucky Bioprocessing
Kentucky Bioprocessing is a global leader in the expression, extraction, and commercialization of proteins and other plant-derived products.
Laboratorios Gebro Pharma
Laboratorios Gebro Pharma is focuses on the development and commercialization of treatments against pain and inflammation.
Lucideon
Lucideon is a development and commercialization organization (DCO), specializing in materials technologies and processes
RareGen
RareGen provides strategy, investment, and commercialization for rare disease pharmaceutical products.
Receptos
Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.
Salient Pharmaceuticals
Salient is developing CASAD™, a proprietary composition proven to adsorb a range of toxins and inflammatory proteins.
ULURU
ULURU engages in the research, development, and commercialization of wound care and mucoadhesive film products.
Current Advisors List
Current Employees Featured
Stock Details
More informations about "Adolor"
About Us - adolore
We are a biotechnology company focused on developing novel therapies for the treatment of chronic pain and other pain and nervous system conditions or disorders. Long-acting, locally-administered, non-opioid analgesic gene …See details»
Home - adolore
Sep 24, 2024 We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of …See details»
Adolore Biotherapeutics - Crunchbase Company Profile & Funding
Adolore Biotherapeutics is a health company that develops disease-modifying non-opoid analgesic gene therapy for eating chronic pain.See details»
Leadership Team - adolore
Our dedicated Leadership Team is committed to leveraging their extensive expertise and experience in drug discovery and development to bring new, innovative, non-opioid …See details»
Adolor - LinkedIn
Adolor Corporation (NASDAQ:ADLR) is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The Company's first ...See details»
Adolor - Crunchbase Company Profile & Funding
Adolor focuses on the discovery, development and commercialization of prescription pain and pain-management products.See details»
Adolore Biotherapeutics - LinkedIn
Adolore Biotherapeutics, Inc., is a biotechnology company focused on developing novel therapies for the treatment of chronic pain and other pain and nervous system conditions or disorders.See details»
Adolore Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical ...
About Adolore BioTherapeutics, Inc. Adolore BioTherapeutics, Inc., is a biotechnology company focused on developing novel non-opioid therapies for treating chronic pain and other pain and …See details»
Adolor Corporation Company Profile | Lexington, MA
Find company research, competitor information, contact details & financial data for Adolor Corporation of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»
Adolore Biotherapeutics 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Adolore Biotherapeutics. Use the PitchBook Platform to explore the full profile.See details»
Adolore Biotherapeutics, Inc. - VentureRadar
Adolore Biotherapeutics, Inc. is a new biotechnology company focused on developing breakthrough opioid-free pain relieving (analgesic) treatments for chronic pain. Our founders …See details»
Adolore BioTherapeutics Outlines Strategy for its Next Generation ...
May 21, 2024 About Adolore BioTherapeutics, Inc. Adolore BioTherapeutics, Inc., is a biotechnology company focused on developing novel therapies for the treatment of chronic …See details»
Adolor 2025 Company Profile: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Adolor. Use the PitchBook Platform to explore the full profile.See details»
Adolore Biotherapeutics - Contacts, Employees, Board Members, …
Adolore Biotherapeutics is a health company that develops disease-modifying non-opoid analgesic gene therapy for eating chronic pain.See details»
Adolor: Revenue, Worth, Valuation & Competitors 2025
About Adolor Adolor is a Pharmaceuticals related company founded in 1993 with 27 employees an estimated revenue of $5.4M, and. It has 10 competitors including Imaging Endpoints, …See details»
Board of Directors - adolore
Paul Barone, MBA, CPA, JD Chief Business Officer, General Counsel, Secretary to BoardSee details»
Adolor - Overview, News & Similar companies | ZoomInfo.com
Jul 18, 2022 Who is Adolor Adolor Corporation (Nasdaq: ADLR) is a biopharmaceutical company specializing in the discovery, development and commercialisation of novel prescrip …See details»
Adolore Biotherapeutics Strengthens Management Team and …
Jan 17, 2023 / Adolore Biotherapeutics, Inc. ("Adolore" or the "Company"), a biotechnology company focused on developing breakthrough opioid-free pain relieving (analgesic) treatments …See details»
Adolore Biotherapeutics to Present Its Gene Therapy Program for …
Feb 22, 2023 Adolore Biotherapeutics, Inc., is a biotechnology company focused on developing novel therapies for the treatment of chronic pain and other pain and nervous system conditions …See details»
Our Pipeline - adolore
Stay up to date and get notifications via email when we post updatesSee details»